Clinical Trials Directory

Trials / Completed

CompletedNCT05341648

Aerobic Exercise and Covid-19 Survivors With Post-Intensive Care Syndrome (Pics)

Effects of Aerobic Exercise Program in Covid-19 Survivors With Post-Intensive Care Syndrome (Pics)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
60 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
30 Years – 60 Years
Healthy volunteers
Not accepted

Summary

To investigate the effects of aerobic exercise program on physical activity, aerobic capacity, anxiety\& depression in Covid-19 survivors discharged from Intensive Care Unit. There is evidence in the literature that post-intensive case survivors who have been mechanically ventilated will likely experience short- and medium-term consequences in the form of Post Intensive Care Syndrome (PICS).

Detailed description

The notion that patients surviving intensive care and mechanical ventilation for several weeks can be discharged home without further medical attention is a dangerous illusion. Post-Intensive Care Syndrome and other severe conditions will require not only adequate screening but early rehabilitation and other interventions. So, this focused control trial will contribute particularly to determining the Effects of the Aerobic Exercise Program in Covid-19 Survivors with Post-Intensive Care Syndrome.

Conditions

Interventions

TypeNameDescription
OTHERAerobic Exercise TrainingWarm-up: 5 minutes Aerobic Training Treadmill/cycle ergometer Frequency:3 days a week Intensity:40-70% of HR max(Start from 40% than increment to as per patient tolerance) Total Duration:6 weeks. Duration of each session:15-30 mins. Cool-down: 5 minutes
OTHERHome Plan* Positions to ease breathlessness * Controlled breathing/Deep breathing\*10 Reps\* TD,s * Progressive Muscle Relaxation Exercises. * ROM \& Flexibility Exercises. 3 days a week for 6 weeks.

Timeline

Start date
2022-04-30
Primary completion
2022-11-01
Completion
2022-11-01
First posted
2022-04-22
Last updated
2022-11-28

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT05341648. Inclusion in this directory is not an endorsement.